Repligen Corp
NASDAQ:RGEN
Repligen Corp
NASDAQ:RGEN
Price:
158.36 USD
-3.56%
Market Closed
Updated:
May 2, 2024
Repligen Corp
Revenue
|
Repligen Corp
Revenue Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Repligen Corp
NASDAQ:RGEN
|
Revenue
$638.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
27%
|
CAGR 10-Years
25%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Repligen Corp
Revenue Breakdown
Breakdown by Geography
Repligen Corp
Repligen Corp
Not Available
Breakdown by Segments
Repligen Corp
Repligen Corp
|
Total Revenue:
638.8m
USD
|
|
Product:
638.4m
USD
|
|
Filtration Products:
347.8m
USD
|
|
Chromatography Products:
126.6m
USD
|
|
Proteins Products:
103.5m
USD
|
|
Process Analytics Products:
56.8m
USD
|
|
Other Products:
3.7m
USD
|
See Also
What is Repligen Corp's Revenue?
Revenue
638.8m
USD
638.8m
USD
Based on the financial report for Dec 31, 2023, Repligen Corp's Revenue amounts to 638.8m USD.
What is Repligen Corp's Revenue growth rate?
Revenue CAGR 10Y
25%
25%
Over the last year, the Revenue growth was -20%. The average annual Revenue growth rates for Repligen Corp have been 20% over the past three years , 27% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
